Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Upton

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Brain Research|December 29, 2004
A novel behavioural registration system LABORAS and the social interaction paradigm detect long-term functional deficits following middle cerebral artery occlusion in the ratLeann P Quinn, Robert I Grundy, Colin A Campbell, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 11, 2003
Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responsesPaola Petrillo, Ornella Angelici, Sharon Bingham, et al.
IUPHAR/BPS Guide to Pharmacology CITE|December 20, 2021
Orexin receptors in GtoPdb v.2021.3Paul Coleman, Luis de Lecea, Anthony Gotter, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
The design of 8,8-dimethyl[1,6]naphthyridines as potential anticonvulsant agentsNigel E Austin, Michael S Hadley, John D Harling, et al.
Journal of Neuroinflammation|February 28, 2007
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesPerdita L Pugh, Martin P Vidgeon-Hart, Tracey Ashmeade, et al.
Journal of Geriatric Psychiatry and Neurology|May 1, 2010
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controlsD P Devanand, Arthur Mikhno, Gregory H Pelton, et al.
Brain Research|March 11, 2009
Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRISatheesh Maheswaran, Hervé Barjat, Daniel Rueckert, et al.
Molecular and Cellular Neurosciences|December 11, 2003
BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changesSteve M Harrison, Alex J Harper, Julie Hawkins, et al.
Plos One|September 21, 2011
Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkersJoshua H Balsters, Redmond G O'Connell, Mary P Martin, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Brain Research|December 29, 2004
A novel behavioural registration system LABORAS and the social interaction paradigm detect long-term functional deficits following middle cerebral artery occlusion in the ratLeann P Quinn, Robert I Grundy, Colin A Campbell, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 11, 2003
Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta, 12bbeta)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responsesPaola Petrillo, Ornella Angelici, Sharon Bingham, et al.
IUPHAR/BPS Guide to Pharmacology CITE|December 20, 2021
Orexin receptors in GtoPdb v.2021.3Paul Coleman, Luis de Lecea, Anthony Gotter, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2002
Pharmacological profile of SB-357134: a potent, selective, brain penetrant, and orally active 5-HT(6) receptor antagonistTania O Stean, Warren D Hirst, David R Thomas, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
The design of 8,8-dimethyl[1,6]naphthyridines as potential anticonvulsant agentsNigel E Austin, Michael S Hadley, John D Harling, et al.
Journal of Neuroinflammation|February 28, 2007
Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenesPerdita L Pugh, Martin P Vidgeon-Hart, Tracey Ashmeade, et al.
Journal of Geriatric Psychiatry and Neurology|May 1, 2010
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controlsD P Devanand, Arthur Mikhno, Gregory H Pelton, et al.
Brain Research|March 11, 2009
Longitudinal regional brain volume changes quantified in normal aging and Alzheimer's APP x PS1 mice using MRISatheesh Maheswaran, Hervé Barjat, Daniel Rueckert, et al.
Molecular and Cellular Neurosciences|December 11, 2003
BACE1 (beta-secretase) transgenic and knockout mice: identification of neurochemical deficits and behavioral changesSteve M Harrison, Alex J Harper, Julie Hawkins, et al.
Plos One|September 21, 2011
Donepezil impairs memory in healthy older subjects: behavioural, EEG and simultaneous EEG/fMRI biomarkersJoshua H Balsters, Redmond G O'Connell, Mary P Martin, et al.
Pageof 6